Company Filing History:
4 out of 1,586 
2 out of 1,153 
Years Active: 2017-2022
Title: Heping Yan: Innovator in Antibody Technologies
Introduction
Heping Yan is a prominent inventor based in St. Louis, MO, who has made significant contributions to the field of biomedical research. With a total of four patents to his name, Yan's work primarily focuses on the development of antibodies targeting specific proteins involved in tumor biology. His innovative approaches have the potential to transform cancer treatment paradigms.
Latest Patents
Yan's latest inventions include two noteworthy patents:
1. **Antibodies to TIP1 and methods of use thereof** - This patent introduces antigen binding proteins that demonstrate utility in recognizing tumor cells, thereby enabling tumor-specific delivery of drugs and therapies.
2. **Antibodies to GRP78** - This invention revolves around isolated antibodies that bind to the protein GRP78, which plays a crucial role in cellular stress responses and tumor development.
Career Highlights
Throughout his career, Heping Yan has worked with prestigious institutions such as Washington University and Vanderbilt University. His research endeavors have strengthened the bridge between basic science and clinical applications, making a lasting impact on therapeutic strategies in oncology.
Collaborations
In his journey, Yan has collaborated with esteemed colleagues, including Dennis E Hallahan and Vaishali Kapoor. These partnerships have further enriched his research and facilitated significant advancements in antibody technology.
Conclusion
Heping Yan's innovative contributions to the field of antibody research underscore the importance of targeted therapies in cancer treatment. His patents not only reflect his expertise as an inventor but also highlight the collaborative spirit present in the scientific community. As the landscape of cancer therapy continues to evolve, Yan's work is likely to inspire future innovations that improve patient outcomes.